Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis

Inflammation and Allergy - Drug Targets

Volumn 6, Issue 1, 2007, Pages 17-26

  Bäumer, Wolfgang ^a   Hoppmann, Joachim ^b   Rundfeldt, Chris ^b   Kietzmann, Manfred ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b Elbion AG   (Germany)

Author keywords

Allergic dermatitis; Atopic dermatitis; PDE4 inhibitors; Phosphodiesterase 4; Psoriasis

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ALEFACEPT; AROFYLLINE; ATIZORAM; CC 10004; CILOMILAST; CIPAMFYLLINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DIFLORASONE DIACETATE; EFALIZUMAB; ETANERCEPT; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INFLIXIMAB; ISA 247; N (3,5 DICHLORO 4 PYRIDYL) [1 (4 FLUOROBENZYL) 5 HYDROXY 3 INDOLYL]GLYOXYLIC ACID AMIDE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; PICLAMILAST; PIMECROLIMUS; PLACEBO; PREDNISOLONE; R 1524; ROFLUMILAST; ROLIPRAM; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABNORMAL LABORATORY RESULT; ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MARKETING; DRUG MEGADOSE; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG WITHDRAWAL; ENZYME INHIBITION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; NAUSEA; NONHUMAN; PREVALENCE; PSORIASIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SIDE EFFECT; SINGLE DRUG DOSE; SKIN ALLERGY; STOMACH ACID SECRETION; UNSPECIFIED SIDE EFFECT; VOMITING;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ANTI-ALLERGIC AGENTS; CLINICAL TRIALS; DERMATITIS, ALLERGIC CONTACT; HUMANS; PHOSPHODIESTERASE INHIBITORS; PSORIASIS;

EID: 33947687574     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152807780077318     Document Type: Article

References (50)

1. Torphy, T.J. Am. J. Respir. Crit Care Med., 1998, 157, 351.
2. Souness, J.E.; Aldous, D.; Sargent, C. Immunopharmacology, 2000, 47, 127.
3. Houslay, M.D.; Schafer, P.; Zhang, K.Y. Drug Discov. Today, 2005, 10, 1503.
4. Giembycz, M.A. Trends Pharmacol. Sci., 2002, 23, 548.
5. Robichaud, A.; Stamatiou, P.B.; Jin, S. L.; Lachance, N.; MacDonald, D.; Laliberte, F.; Liu, S.; Huang, Z.; Conti, M.; Chan, C.C. J. Clin. Invest., 2002, 110, 1045.
6. Manning, C.D.; Burman, M.; Christensen, S.B.; Cieslinski, L.B.; Essayan, D.M.; Grous, M.; Torphy, T.J.; Barnette, M.S. Br. J. Pharmacol., 1999, 128, 1393.
7. Ariga, M.; Neitzert, B.; Nakae, S.; Mottin, G.; Bertrand, C.; Pruniaux, M.P.; Jin, S. L.; Conti, M. J. Immunol., 2004, 173, 7531.
8. Draheim, R.; Egerland, U.; Rundfeldt, C. J. Pharmacol. Exp. Ther., 2004, 308, 555.
9. Cohan, V.L.; Showell, H.J.; Fisher, D.A.; Pazoles, C.J.; Eatson, J.W.; Turner, C.R.; Cheng, J.B. J. Pharmacol. Exp. Ther., 1996, 278, 1356.
10. Khobzaoui, M.; Gutke, H.J.; Burnet, M. Curr. Opin. Investig. Drugs, 2005, 6, 518.
11. Lipworth, B.J. Lancet, 2005, 365, 167.
12. Akdis, C.A.; Akdis, M.; Bieber, T.; Bindslev-Jensen, C.; Boguniewicz, M.; Eigenmann, P.; Hamid, Q.; Kapp, A.; Leung, D.Y.; Lipozencic, J.; Luger, T.A.; Muraro, A.; Novak, N.; Platts-Mills, T.A.; Rosenwasser, L.; Scheynius, A.; Simons, F. E.; Spergel, J.; Turjanmaa, K.; Wahn, U.; Weidinger, S.; Werfel, T.; Zuberbier, T. J. Allergy Clin. Immunol., 2006, 118, 152.
13. Leung, D.Y.; Bieber, T. Lancet, 2003, 361, 151.
14. Fonacier, L.; Spergel, J.; Charlesworth, E.N.; Weldon, D.; Beltrani, V.; Bernhisel-Broadbent, J.; Boguniewicz, M.; Leung, D.Y. J. Allergy Clin. Immunol., 2005, 115, 1249.
15. Ring, J.; Barker, J.; Behrendt, H.; Braathen, L.; Darsow, U.; Dubertret, L.; Giannetti, A.; Hawk, J.; Honigsmann, H.; Kemeny, L.; Luger, T.; Meurer, M.; Murphy, G.; Peserico, A.; Ranki, A.; Reunala, T.; Saurat, J.; Sterry, W.; van de Kerkhof, P. J. Eur. Acad. Dermatol. Venereol., 2005, 19, 663.
16. "Pipelines and Commercial Perspectives: Psoriasis and Atopic Dermatitis"; DMHC1935; Delaney, A., editor, Datamonitor: 2003.
17. Boehncke, W.H.; Prinz, J., Gottlieb, A.B. J. Rheumatol., 2006, 33, 1447.
18. Bissonnette, R.; Papp, K.; Poulin, Y.; Lauzon, G.; Aspeslet, L.; Huizinga, R.; Mayo, P.; Foster, R.T.; Yatscoff, R.W.; Maksymowych, W.P. J. Am. Acad. Dermatol., 2006, 54, 472.
19. Krause, W.; Kuhne, G. Arzneimittelforschung, 1994, 44, 163.
20. Teixeira, M.M.; Rossi, A.G.; Williams, T.J.; Hellewell, P.G. Br. J. Pharmacol., 1994, 112, 332.
21. Harada, D.; Tsukumo, Y.; Takashima, Y.; Manabe, H. Eur. J. Pharmacol., 2006, 532, 128.
22. Ehinger, A.M.; Gorr, G.; Hoppmann, J.; Telser, E.; Ehinger, B.; Kietzmann, M. Eur. J. Pharmacol., 2000, 392, 93.
23. Giembycz, M.A. Expert. Opin. Investig. Drugs, 2001, 10, 1361.
24. Giembycz, M.A. Proc. Am. Thorac. Soc., 2005, 2, 326.
25. Baumer, W.; Szelenyi, I.; Kietzmann, M. Expert Rev. Clin. Immunol., 2005, 1, 27.
26. Cooper, N.; Teixeira, M.M.; Warneck, J.; Miotla, J.M.; Wills, R.E.; Macari, D.M.; Gristwood, R.W.; Hellewell, P.G. Br. J. Pharmacol., 1999, 126, 1863.
27. Griswold, D.E.; Webb, E.F.; Badger, A.M.; Gorycki, P.D.; Levandoski, P.A.; Barnette, M.A.; Grous, M.; Christensen, S.; Torphy, T.J. J. Pharmacol. Exp. Ther., 1998, 287, 705.
28. Baumer, W.; Gorr, G.; Hoppmann, J.; Ehinger, A.M.; Ehinger, B.; Kietzmann, M. Eur. J. Pharmacol., 2002, 446, 195.
29. Baumer, W.; Gorr, G.; Hoppmann, J.; Ehinger, A.M.; Rundfeldt, C.; Kietzmann, M. J. Pharm. Pharmacol., 2003, 55, 1107.
30. Baumer, W.; Seegers, U.; Braun, M.; Tschemig, T.; Kietzmann, M. Br. J. Dermatol., 2004, 151, 823.
31. Baumer, W.; Tschernig, T.; Sulzle, B.; Seegers, U.; Luhrmann, A.; Kietzmann, M. Eur. J. Pharmacol., 2003, 481, 271.
32. Heystek, H. C.; Thierry, A. C.; Soulard, P.; Moulon, C. Int. Immunol., 2003, 15, 827.
33. Baumer, W.; Sulzle, B.; Weigt, H.; De Vries, V. C.; Hecht, M.; Tschemig, T.; Kietzmann, M. Br. J. Dermatol., 2005, 153, 136.
34. Baumer, W.; Kietzmann, M. Vet. Dermatol., 2007 (in press).
35. Kuss, H.; Hoefgen, N.; Johanssen, S.; Kronbach, T.; Rundfeldt, C. J. Pharmacol. Exp. Ther., 2003, 307, 373.
36. Hoppmann, J.; Baumer, W.; Galetzka, C.; Hofgen, N.; Kietzmann, M.; Rundfeldt, C. J. Pharm. Pharmacol., 2005, 57, 1609.
37. Molostvov, G.; Morris, A.; Rose, P.; Basu, S.; Muller, G. Br. J. Haematol, 2004, 124, 366.
38. Dyke, H.J.; Montana, J.G. Expert. Opin. Investig. Drugs, 2002, 11, 1.
39. Goyarts, E.; Mammone, T.; Muizzuddin, N.; Marenus, K.; Maes, D. Skin Pharmacol. Appl. Skin Physiol, 2000, 13, 86.
40. Kucharekova, M.; Hornix, M.; Ashikaga, T.; T'kint, S.; de Jongh, G. J.; Schalkwijk, J.; van de Kerkhof, P.C.; van der Valk, P.G. Arch. Dermatol. Res., 2003, 295, 29.
41. Stawiski, M.A.; Rusin, L.J.; Burns, T.L.; Weinstein, G.D.; Voorhees, J.J. J. Invest Dermatol., 1979, 73, 261.
42. Griffiths, C.E.; Van Leent, E.J.; Gilbert, M.; Traulsen, J. Br. J. Dermatol., 2002, 147, 299.
43. Levin, C.; Zhai, H.; Bashir, S.; Chew, A. L.; Anigbogu, A.; Stern, R.; Maibach, H. Skin Res. Technol., 2001, 7, 214.
44. Hanifin, J.M.; Chan, S.C.; Cheng, J.B.; Tofte, S.J.; Henderson, W.R.; Kirby, D.S.; Weiner, E.S. J. Invest Dermatol., 1996, 107, 51.
45. Ferrer, L.; Alberola, J.; Queralt, M.; Brazis, P.; Rabanal, R.; Llenas, J.; Puigdemont, A. Vet. Rec., 1999, 145, 191.
46. Christie, P. Drugs Today (Barc.), 2005, 41, 667.
47. Timmer, W.; Leclerc, V.; Birraux, G.; Neuhauser, M.; Hatzelmann, A.; Bethke, T.; Wurst, W. J. Clin. Pharmacol., 2002, 42, 297.
48. Giembycz, M.A. Curr. Opin. Pharmacol, 2005, 5, 238.
49. Hatzelmann, A.; Schudt, C. J. Pharmacol. Exp. Ther., 2001, 297, 267.
50. Essayan, D.M.; Kagey-Sobotka, A.; Lichtenstein, L.M.; Huang, S.K. J. Pharmacol. Exp. Ther., 1997, 282, 505.